Envision Healthcare Co. (NYSE:EVHC) has been assigned an average rating of “Buy” from the fifteen research firms that are covering the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $73.14.

A number of analysts recently issued reports on EVHC shares. Zacks Investment Research upgraded Envision Healthcare from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a report on Wednesday, February 1st. Cantor Fitzgerald reiterated an “overweight” rating on shares of Envision Healthcare in a report on Thursday, March 16th. Royal Bank of Canada reiterated an “outperform” rating and issued a $80.00 price target (down previously from $87.00) on shares of Envision Healthcare in a report on Wednesday, March 1st. Canaccord Genuity reiterated a “buy” rating and issued a $86.00 price target on shares of Envision Healthcare in a report on Tuesday, April 18th. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $82.00 price target (down previously from $90.00) on shares of Envision Healthcare in a report on Wednesday, March 1st.

Envision Healthcare (NYSE:EVHC) opened at 56.95 on Friday. The stock’s market cap is $6.61 billion. Envision Healthcare has a 1-year low of $53.12 and a 1-year high of $82.37. The stock has a 50 day moving average price of $59.01 and a 200-day moving average price of $55.93.

Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $0.69 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.69. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $2.52 billion. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. On average, equities analysts expect that Envision Healthcare will post $1.40 EPS for the current year.

In other news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction on Wednesday, May 3rd. The stock was sold at an average price of $60.53, for a total transaction of $90,795.00. Following the completion of the sale, the insider now owns 114,363 shares in the company, valued at approximately $6,922,392.39. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In the last 90 days, insiders have sold 4,500 shares of company stock valued at $280,305. 2.30% of the stock is owned by company insiders.

Several hedge funds have recently modified their holdings of EVHC. Seven Bridges Advisors LLC acquired a new stake in shares of Envision Healthcare during the third quarter valued at approximately $119,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Envision Healthcare during the first quarter valued at approximately $135,000. Korea Investment CORP acquired a new stake in shares of Envision Healthcare during the first quarter valued at approximately $141,000. Pacer Advisors Inc. raised its stake in shares of Envision Healthcare by 7.4% in the third quarter. Pacer Advisors Inc. now owns 7,045 shares of the company’s stock valued at $157,000 after buying an additional 484 shares in the last quarter. Finally, Ameritas Investment Partners Inc. acquired a new stake in shares of Envision Healthcare during the first quarter valued at approximately $172,000. Hedge funds and other institutional investors own 35.96% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/05/12/envision-healthcare-co-evhc-given-average-rating-of-buy-by-analysts-2.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

5 Day Chart for NYSE:EVHC

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.